OBJECTIVE To investigate the active compounds of Erigeron breviscapus for curing cadiocerebral disease by analyzing Erigerontis injection and Breviscapine tablet.

• 目的通过对灯盏细辛两种主要制剂的分析,探讨灯盏细辛注射液在治疗心脑血管疾病方面的物质基础。